BamSEC and AlphaSense Join Forces
Learn More

Xenon Pharmaceuticals Inc.

NASDAQ: XENE    
Share price (1/8/25): $39.55    
Market cap (1/8/25): $3.015 billion

Articles of Incorporation Filter

EX-3.1
from 8-K 15 pages Schedule Xenon Pharmaceuticals Inc. Articles of Amendment
12/34/56
EX-3.2
from 10-Q 17 pages Amended and Restated By-Law No. 1 a By-Law Relating Generally to the Transaction of the Business and Affairs of Xenon Pharmaceuticals Inc. Article 1 Interpretation
12/34/56
EX-3.1
from 10-Q 5 pages Schedule a Xenon Pharmaceuticals Inc. Restated Articles of Incorporation Exhibit 1
12/34/56
EX-3.1
from S-1/A 7 pages Industry Canada Industrie Canada Canada Business Corporations Act (Cbca) Form 7 Restated Articles of Incorporation (Section 180) 1 - Corporate Name Xenon Pharmaceuticals Inc. 2 - Corporation Number 375 8 65 6 3 - The Province or Territory in Canada Where the Registered Office Is Situated (Do Not Indicate the Full Address) British Columbia 4 - The Classes and Any Maximum Number of Shares That the Corporation Is Authorized to Issue See Attached Schedule a 5 - Restrictions, if Any, on Share Transfers Not Applicable 6 - Minimum and Maximum Number of Directors (For a Fixed Number of Directors, Please Indicate the Same Number in Both Boxes) Minimum Number 110 Maximum Number 7 - Restrictions, if Any, on the Business the Corporation May Carry on Not Applicable 8 - Other Provisions, if Any See Attached Schedule B 9 - Declaration
12/34/56
EX-3.2
from S-1 14 pages Amended and Restated By-Law No. 1 a By-Law Relating Generally to the Transaction of the Business and Affairs of Xenon Pharmaceuticals Inc. Article 1 Interpretation
12/34/56
EX-3
from DRS/A 14 pages Amended and Restated By-Law No. 1 a By-Law Relating Generally to the Transaction of the Business and Affairs of Xenon Pharmaceuticals Inc. Article 1 Interpretation
12/34/56